Yao Liu

Title: Yao Liu: Innovator in Pharmaceutical Composition for Cancer Treatment

Introduction

Yao Liu is a prominent inventor based in Lianyungang, China. He has made significant contributions to the field of biomedicine, particularly in the development of pharmaceutical compositions aimed at treating various types of cancer. His innovative work has the potential to impact the lives of many patients suffering from serious health conditions.

Latest Patents

Yao Liu holds a patent for a combined pharmaceutical composition for treating tumors. This patent, which is particularly relevant in the field of biomedicine, focuses on a composition that targets biliary tract tumors, liver cancer, triple-negative breast cancer, and lung cancer. The composition includes an anti-PD-L1 antibody and anlotinib, demonstrating effective anti-cancer activity.

Career Highlights

Throughout his career, Yao Liu has worked with notable companies in the pharmaceutical industry. He has been associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. and Nanjing Shunxin Pharmaceuticals Co., Ltd., both of which are part of the Chiatai Tianqing Pharmaceutical Group. His experience in these organizations has contributed to his expertise in developing innovative cancer treatments.

Collaborations

Yao Liu has collaborated with several professionals in his field, including Xiquan Zhang and Xunqiang Wang. These collaborations have likely enhanced his research and development efforts, leading to advancements in cancer treatment.

Conclusion

Yao Liu is a dedicated inventor whose work in pharmaceutical compositions for cancer treatment showcases his commitment to improving patient outcomes. His innovative approach and collaborations with industry professionals highlight the importance of teamwork in advancing medical science.